microRNA information: hsa-miR-181d-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-181d-5p | miRbase |
| Accession: | MIMAT0002821 | miRbase |
| Precursor name: | hsa-mir-181d | miRbase |
| Precursor accession: | MI0003139 | miRbase |
| Symbol: | MIR181D | HGNC |
| RefSeq ID: | NR_030179 | GenBank |
| Sequence: | AACAUUCAUUGUUGUCGGUGGGU |
Reported expression in cancers: hsa-miR-181d-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-181d-5p | breast cancer | deregulation | "In line with our quantitative PCR analysis data in ......" | 26697527 | qPCR |
| hsa-miR-181d-5p | gastric cancer | upregulation | "By integrating CNV and miRNA profiles in the same ......" | 23553990 | qPCR |
| hsa-miR-181d-5p | gastric cancer | upregulation | "MicroRNA arrays identified differences in the miRN ......" | 26939869 | Microarray |
| hsa-miR-181d-5p | head and neck cancer | deregulation | "Real-time polymerase chain reaction PCR analysis c ......" | 21560177 | qPCR |
| hsa-miR-181d-5p | liver cancer | upregulation | "Up-regulation of miR-15a miR-16 miR-27b miR-30b mi ......" | 24314246 | qPCR |
Reported cancer pathway affected by hsa-miR-181d-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-181d-5p | endometrial cancer | Apoptosis pathway | "Moreover hsa-miR-181d was upregulated to control e ......" | 27006767 | |
| hsa-miR-181d-5p | esophageal cancer | cell cycle pathway | "MicroRNA 181d is a tumor suppressor in human esoph ......" | 27572270 | Luciferase |
| hsa-miR-181d-5p | pancreatic cancer | MAPK signaling pathway | "In our previous studies we identified four microRN ......" | 27380024 |
Reported cancer prognosis affected by hsa-miR-181d-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-181d-5p | breast cancer | poor survival | "To investigate the global expression profile of mi ......" | 18812439 | |
| hsa-miR-181d-5p | gastric cancer | cell migration; drug resistance | "MicroRNA arrays identified differences in the miRN ......" | 26939869 | |
| hsa-miR-181d-5p | glioblastoma | poor survival; drug resistance | "Genome-wide microRNA miRNA profiling of 82 gliobla ......" | 22570426 | Luciferase |
| hsa-miR-181d-5p | liver cancer | drug resistance | "The cell viability MTT assay was used to detect dr ......" | 23229111 | MTT assay |
| hsa-miR-181d-5p | ovarian cancer | poor survival | "We measured the expression of nine miRNAs miR-181d ......" | 22925189 | |
| hsa-miR-181d-5p | pancreatic cancer | metastasis | "In our previous studies we identified four microRN ......" | 27380024 |
Reported gene related to hsa-miR-181d-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-181d-5p | glioblastoma | MGMT | "In silico analyses of The Cancer Genome Atlas TCGA ......" | 27057640 |
| hsa-miR-181d-5p | glioblastoma | MGMT | "Bioinformatic analysis of potential genes regulate ......" | 22570426 |
| hsa-miR-181d-5p | glioblastoma | MGMT | "We previously demonstrated that MGMT expression is ......" | 24994119 |
| hsa-miR-181d-5p | esophageal cancer | DERL1 | "MicroRNA 181d is a tumor suppressor in human esoph ......" | 27572270 |
| hsa-miR-181d-5p | endometrial cancer | PTEN | "Moreover hsa-miR-181d was upregulated to control e ......" | 27006767 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-181d-5p | PGAM1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.127; TCGA CESC -0.139; TCGA COAD -0.214; TCGA ESCA -0.214; TCGA HNSC -0.254; TCGA LGG -0.098; TCGA LIHC -0.063; TCGA LUAD -0.12; TCGA LUSC -0.264; TCGA SARC -0.051; TCGA THCA -0.228; TCGA STAD -0.119; TCGA UCEC -0.11 |
hsa-miR-181d-5p | SAMHD1 | 9 cancers: BLCA; BRCA; CESC; KIRP; LUAD; OV; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.303; TCGA BRCA -0.268; TCGA CESC -0.151; TCGA KIRP -0.223; TCGA LUAD -0.345; TCGA OV -0.086; TCGA PAAD -0.257; TCGA SARC -0.19; TCGA THCA -0.31 |
hsa-miR-181d-5p | SOAT1 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LUAD; OV; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.136; TCGA BRCA -0.097; TCGA KIRC -0.085; TCGA KIRP -0.131; TCGA LUAD -0.141; TCGA OV -0.076; TCGA SARC -0.202; TCGA THCA -0.229; TCGA UCEC -0.095 |
hsa-miR-181d-5p | CCL8 | 9 cancers: BLCA; BRCA; COAD; KIRP; LUAD; LUSC; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.5; TCGA BRCA -0.329; TCGA COAD -0.36; TCGA KIRP -0.782; TCGA LUAD -0.4; TCGA LUSC -0.218; TCGA PAAD -0.557; TCGA SARC -0.566; TCGA THCA -0.462 |
hsa-miR-181d-5p | PAFAH1B2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.117; TCGA BRCA -0.128; TCGA ESCA -0.118; TCGA HNSC -0.126; TCGA KIRC -0.216; TCGA KIRP -0.184; TCGA LUAD -0.144; TCGA LUSC -0.074; TCGA THCA -0.192 |
hsa-miR-181d-5p | FAM135A | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.112; TCGA BRCA -0.083; TCGA CESC -0.405; TCGA ESCA -0.266; TCGA HNSC -0.279; TCGA KIRC -0.116; TCGA LUAD -0.136; TCGA LUSC -0.123; TCGA THCA -0.055 |
hsa-miR-181d-5p | SUCLG2 | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.093; TCGA BRCA -0.08; TCGA HNSC -0.102; TCGA KIRC -0.354; TCGA KIRP -0.217; TCGA LIHC -0.147; TCGA LUSC -0.061; TCGA OV -0.103; TCGA PRAD -0.072; TCGA SARC -0.079; TCGA THCA -0.208; TCGA STAD -0.315 |
hsa-miR-181d-5p | MINK1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.069; TCGA CESC -0.243; TCGA COAD -0.122; TCGA ESCA -0.249; TCGA HNSC -0.218; TCGA LUAD -0.106; TCGA LUSC -0.112; TCGA SARC -0.061; TCGA THCA -0.092; TCGA STAD -0.221; TCGA UCEC -0.095 |
hsa-miR-181d-5p | PSAP | 9 cancers: BLCA; BRCA; KIRC; KIRP; LUAD; OV; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.08; TCGA BRCA -0.074; TCGA KIRC -0.073; TCGA KIRP -0.18; TCGA LUAD -0.15; TCGA OV -0.068; TCGA SARC -0.236; TCGA THCA -0.109; TCGA STAD -0.126 |
hsa-miR-181d-5p | LRRFIP1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.195; TCGA BRCA -0.133; TCGA COAD -0.083; TCGA ESCA -0.194; TCGA HNSC -0.268; TCGA LUAD -0.111; TCGA LUSC -0.097; TCGA SARC -0.099; TCGA THCA -0.119; TCGA UCEC -0.065 |
hsa-miR-181d-5p | ADM | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; SARC; STAD | MirTarget | TCGA BLCA -0.247; TCGA BRCA -0.174; TCGA CESC -0.188; TCGA COAD -0.168; TCGA ESCA -0.346; TCGA HNSC -0.187; TCGA KIRP -0.535; TCGA LGG -0.297; TCGA LUSC -0.353; TCGA SARC -0.304; TCGA STAD -0.298 |
hsa-miR-181d-5p | DGKH | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; THCA; UCEC | MirTarget | TCGA BLCA -0.147; TCGA BRCA -0.118; TCGA CESC -0.279; TCGA HNSC -0.14; TCGA LUAD -0.179; TCGA LUSC -0.142; TCGA OV -0.125; TCGA THCA -0.152; TCGA UCEC -0.109 |
hsa-miR-181d-5p | KANK1 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; THCA | MirTarget | TCGA BLCA -0.167; TCGA CESC -0.209; TCGA ESCA -0.279; TCGA HNSC -0.411; TCGA KIRC -0.134; TCGA KIRP -0.091; TCGA LIHC -0.155; TCGA LUSC -0.124; TCGA THCA -0.151 |
hsa-miR-181d-5p | EPB41L3 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; OV; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.173; TCGA BRCA -0.292; TCGA HNSC -0.158; TCGA KIRC -0.352; TCGA KIRP -0.221; TCGA LUAD -0.201; TCGA OV -0.137; TCGA SARC -0.337; TCGA THCA -0.452; TCGA UCEC -0.131 |
hsa-miR-181d-5p | TSC22D2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; THCA | MirTarget | TCGA BLCA -0.081; TCGA BRCA -0.08; TCGA ESCA -0.203; TCGA HNSC -0.319; TCGA KIRC -0.131; TCGA KIRP -0.231; TCGA LIHC -0.084; TCGA LUAD -0.285; TCGA THCA -0.091 |
hsa-miR-181d-5p | CLIP1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.179; TCGA BRCA -0.106; TCGA CESC -0.178; TCGA ESCA -0.166; TCGA HNSC -0.279; TCGA KIRC -0.105; TCGA LIHC -0.071; TCGA LUAD -0.118; TCGA LUSC -0.079; TCGA SARC -0.091; TCGA THCA -0.164; TCGA UCEC -0.088 |
hsa-miR-181d-5p | GHITM | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.136; TCGA BRCA -0.081; TCGA CESC -0.094; TCGA ESCA -0.113; TCGA HNSC -0.137; TCGA KIRC -0.288; TCGA KIRP -0.257; TCGA LIHC -0.134; TCGA LUSC -0.121; TCGA OV -0.101; TCGA PRAD -0.052; TCGA THCA -0.226; TCGA STAD -0.225 |
hsa-miR-181d-5p | PI4K2B | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; OV; SARC; THCA | MirTarget | TCGA BLCA -0.054; TCGA BRCA -0.052; TCGA CESC -0.121; TCGA ESCA -0.111; TCGA HNSC -0.111; TCGA KIRC -0.13; TCGA KIRP -0.079; TCGA LIHC -0.235; TCGA OV -0.089; TCGA SARC -0.076; TCGA THCA -0.23 |
hsa-miR-181d-5p | RAD23B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PRAD; SARC | MirTarget | TCGA BLCA -0.065; TCGA BRCA -0.068; TCGA CESC -0.1; TCGA COAD -0.073; TCGA ESCA -0.094; TCGA HNSC -0.133; TCGA KIRC -0.091; TCGA KIRP -0.091; TCGA LIHC -0.108; TCGA LUAD -0.065; TCGA OV -0.055; TCGA PRAD -0.093; TCGA SARC -0.091 |
hsa-miR-181d-5p | UBE3C | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.073; TCGA BRCA -0.057; TCGA CESC -0.094; TCGA ESCA -0.127; TCGA HNSC -0.138; TCGA KIRC -0.083; TCGA LUAD -0.102; TCGA LUSC -0.103; TCGA THCA -0.118 |
hsa-miR-181d-5p | PPP2R5E | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.086; TCGA BRCA -0.094; TCGA CESC -0.081; TCGA COAD -0.058; TCGA ESCA -0.092; TCGA HNSC -0.181; TCGA KIRC -0.099; TCGA LUAD -0.063; TCGA LUSC -0.103; TCGA THCA -0.139 |
hsa-miR-181d-5p | HEATR3 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.068; TCGA BRCA -0.063; TCGA HNSC -0.171; TCGA KIRC -0.078; TCGA KIRP -0.106; TCGA LUSC -0.147; TCGA PAAD -0.148; TCGA PRAD -0.106; TCGA SARC -0.136; TCGA THCA -0.17 |
hsa-miR-181d-5p | NPTN | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; UCEC | MirTarget | TCGA BLCA -0.129; TCGA BRCA -0.094; TCGA COAD -0.121; TCGA HNSC -0.065; TCGA KIRC -0.081; TCGA KIRP -0.128; TCGA LUAD -0.072; TCGA LUSC -0.126; TCGA UCEC -0.096 |
hsa-miR-181d-5p | ACER3 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.073; TCGA BRCA -0.243; TCGA COAD -0.102; TCGA ESCA -0.121; TCGA HNSC -0.144; TCGA KIRC -0.139; TCGA KIRP -0.103; TCGA LUAD -0.183; TCGA OV -0.136; TCGA PAAD -0.169; TCGA SARC -0.153; TCGA THCA -0.22 |
hsa-miR-181d-5p | BMP2K | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.173; TCGA BRCA -0.145; TCGA CESC -0.134; TCGA ESCA -0.222; TCGA HNSC -0.266; TCGA KIRP -0.162; TCGA LUAD -0.168; TCGA PAAD -0.231; TCGA SARC -0.215; TCGA THCA -0.32 |
hsa-miR-181d-5p | CSF2RB | 9 cancers: BLCA; BRCA; KIRP; LUAD; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.305; TCGA BRCA -0.175; TCGA KIRP -0.267; TCGA LUAD -0.225; TCGA PAAD -0.421; TCGA SARC -0.396; TCGA THCA -0.312; TCGA STAD -0.338; TCGA UCEC -0.169 |
hsa-miR-181d-5p | CD48 | 11 cancers: BLCA; BRCA; CESC; KIRP; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.429; TCGA BRCA -0.116; TCGA CESC -0.194; TCGA KIRP -0.251; TCGA LUAD -0.13; TCGA OV -0.198; TCGA PAAD -0.468; TCGA SARC -0.331; TCGA THCA -0.493; TCGA STAD -0.4; TCGA UCEC -0.121 |
hsa-miR-181d-5p | ARHGEF3 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.093; TCGA BRCA -0.069; TCGA CESC -0.138; TCGA HNSC -0.161; TCGA KIRC -0.193; TCGA KIRP -0.135; TCGA LUAD -0.119; TCGA PAAD -0.157; TCGA SARC -0.073; TCGA THCA -0.178 |
hsa-miR-181d-5p | TEX2 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.105; TCGA BRCA -0.093; TCGA CESC -0.085; TCGA ESCA -0.12; TCGA HNSC -0.107; TCGA KIRP -0.164; TCGA LIHC -0.09; TCGA LUAD -0.087; TCGA LUSC -0.108; TCGA THCA -0.305 |
hsa-miR-181d-5p | MAGI3 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; THCA; STAD | MirTarget | TCGA BLCA -0.075; TCGA CESC -0.108; TCGA ESCA -0.199; TCGA HNSC -0.14; TCGA KIRC -0.252; TCGA KIRP -0.116; TCGA LIHC -0.092; TCGA LUAD -0.164; TCGA THCA -0.161; TCGA STAD -0.121 |
hsa-miR-181d-5p | GPRIN3 | 10 cancers: BLCA; BRCA; KIRC; KIRP; LUAD; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.246; TCGA BRCA -0.161; TCGA KIRC -0.167; TCGA KIRP -0.304; TCGA LUAD -0.15; TCGA PAAD -0.262; TCGA SARC -0.121; TCGA THCA -0.563; TCGA STAD -0.239; TCGA UCEC -0.171 |
hsa-miR-181d-5p | SLC25A25 | 10 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUAD; OV; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.153; TCGA COAD -0.09; TCGA KIRC -0.251; TCGA KIRP -0.448; TCGA LIHC -0.224; TCGA LUAD -0.076; TCGA OV -0.1; TCGA PRAD -0.08; TCGA THCA -0.285; TCGA UCEC -0.101 |
hsa-miR-181d-5p | SLK | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; THCA; UCEC | MirTarget | TCGA BLCA -0.094; TCGA BRCA -0.119; TCGA CESC -0.224; TCGA COAD -0.098; TCGA ESCA -0.16; TCGA HNSC -0.3; TCGA KIRC -0.083; TCGA LUAD -0.093; TCGA THCA -0.184; TCGA UCEC -0.073 |
hsa-miR-181d-5p | UBE2D3 | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; SARC; STAD | MirTarget | TCGA BLCA -0.057; TCGA CESC -0.104; TCGA HNSC -0.155; TCGA KIRC -0.079; TCGA KIRP -0.051; TCGA LIHC -0.073; TCGA LUAD -0.063; TCGA SARC -0.068; TCGA STAD -0.11 |
hsa-miR-181d-5p | TTC39B | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.331; TCGA BRCA -0.118; TCGA CESC -0.319; TCGA ESCA -0.377; TCGA HNSC -0.325; TCGA KIRC -0.344; TCGA KIRP -0.391; TCGA LUAD -0.182; TCGA LUSC -0.242; TCGA OV -0.127; TCGA PAAD -0.165; TCGA THCA -0.151; TCGA STAD -0.187 |
hsa-miR-181d-5p | LEPROT | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; OV; THCA | MirTarget | TCGA BLCA -0.267; TCGA BRCA -0.238; TCGA ESCA -0.191; TCGA HNSC -0.209; TCGA KIRC -0.165; TCGA KIRP -0.215; TCGA LUAD -0.135; TCGA OV -0.062; TCGA THCA -0.149 |
hsa-miR-181d-5p | WNK1 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; THCA; UCEC | MirTarget | TCGA BLCA -0.093; TCGA BRCA -0.058; TCGA CESC -0.137; TCGA HNSC -0.12; TCGA KIRC -0.328; TCGA KIRP -0.333; TCGA LUAD -0.123; TCGA THCA -0.146; TCGA UCEC -0.054 |
hsa-miR-181d-5p | STARD4 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUAD; THCA; STAD | MirTarget | TCGA BLCA -0.329; TCGA BRCA -0.103; TCGA COAD -0.102; TCGA HNSC -0.162; TCGA KIRP -0.146; TCGA LIHC -0.204; TCGA LUAD -0.137; TCGA THCA -0.352; TCGA STAD -0.242 |
hsa-miR-181d-5p | SEC24A | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.071; TCGA BRCA -0.177; TCGA COAD -0.12; TCGA ESCA -0.239; TCGA HNSC -0.158; TCGA KIRC -0.078; TCGA KIRP -0.166; TCGA LIHC -0.121; TCGA THCA -0.155; TCGA STAD -0.219; TCGA UCEC -0.058 |
hsa-miR-181d-5p | HIPK3 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; THCA; UCEC | MirTarget | TCGA BLCA -0.329; TCGA BRCA -0.266; TCGA ESCA -0.257; TCGA HNSC -0.242; TCGA KIRC -0.238; TCGA KIRP -0.257; TCGA LUAD -0.146; TCGA THCA -0.231; TCGA UCEC -0.121 |
hsa-miR-181d-5p | ENDOD1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; UCEC | MirTarget | TCGA BLCA -0.152; TCGA BRCA -0.065; TCGA COAD -0.1; TCGA ESCA -0.214; TCGA HNSC -0.209; TCGA LUAD -0.122; TCGA LUSC -0.205; TCGA OV -0.11; TCGA PRAD -0.113; TCGA UCEC -0.134 |
hsa-miR-181d-5p | KAT2B | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; THCA; STAD | MirTarget | TCGA BRCA -0.284; TCGA CESC -0.17; TCGA ESCA -0.25; TCGA HNSC -0.291; TCGA KIRC -0.112; TCGA KIRP -0.296; TCGA LIHC -0.281; TCGA LUAD -0.13; TCGA THCA -0.153; TCGA STAD -0.194 |
hsa-miR-181d-5p | ZNRF2 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; OV; PRAD; STAD | MirTarget | TCGA BRCA -0.078; TCGA CESC -0.09; TCGA ESCA -0.113; TCGA HNSC -0.124; TCGA KIRC -0.231; TCGA LIHC -0.118; TCGA LUSC -0.105; TCGA OV -0.092; TCGA PRAD -0.134; TCGA STAD -0.092 |
hsa-miR-181d-5p | ATP11B | 9 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; THCA; STAD | MirTarget | TCGA BRCA -0.102; TCGA CESC -0.198; TCGA ESCA -0.228; TCGA HNSC -0.136; TCGA LUAD -0.088; TCGA LUSC -0.112; TCGA OV -0.1; TCGA THCA -0.056; TCGA STAD -0.091 |
hsa-miR-181d-5p | TMEM184C | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.105; TCGA HNSC -0.076; TCGA KIRC -0.188; TCGA KIRP -0.145; TCGA LIHC -0.055; TCGA LUAD -0.074; TCGA PRAD -0.067; TCGA THCA -0.097; TCGA STAD -0.088 |
hsa-miR-181d-5p | SCD | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD | MirTarget | TCGA BRCA -0.395; TCGA CESC -0.219; TCGA HNSC -0.235; TCGA KIRP -0.167; TCGA LIHC -0.292; TCGA LUAD -0.204; TCGA LUSC -0.158; TCGA OV -0.23; TCGA PRAD -0.262 |
hsa-miR-181d-5p | CHMP2B | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; OV; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.051; TCGA CESC -0.073; TCGA HNSC -0.166; TCGA KIRC -0.128; TCGA KIRP -0.091; TCGA LUAD -0.118; TCGA OV -0.061; TCGA SARC -0.089; TCGA THCA -0.139; TCGA STAD -0.076 |
hsa-miR-181d-5p | PRDX3 | 10 cancers: BRCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.056; TCGA KIRC -0.263; TCGA KIRP -0.197; TCGA LGG -0.064; TCGA LIHC -0.155; TCGA LUSC -0.063; TCGA OV -0.088; TCGA PRAD -0.114; TCGA THCA -0.099; TCGA STAD -0.128 |
hsa-miR-181d-5p | TMEM144 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.158; TCGA HNSC -0.142; TCGA KIRC -0.081; TCGA KIRP -0.179; TCGA LUAD -0.074; TCGA LUSC -0.09; TCGA SARC -0.236; TCGA THCA -0.066; TCGA STAD -0.325 |
hsa-miR-181d-5p | GOLGA1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.07; TCGA CESC -0.08; TCGA COAD -0.067; TCGA ESCA -0.153; TCGA HNSC -0.052; TCGA LIHC -0.081; TCGA PRAD -0.056; TCGA THCA -0.081; TCGA UCEC -0.053 |
hsa-miR-181d-5p | RNF6 | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; THCA | MirTarget | TCGA BRCA -0.09; TCGA CESC -0.108; TCGA HNSC -0.111; TCGA KIRC -0.062; TCGA KIRP -0.102; TCGA LUAD -0.075; TCGA LUSC -0.078; TCGA OV -0.068; TCGA PRAD -0.054; TCGA THCA -0.146 |
hsa-miR-181d-5p | ACSL1 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; OV; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.433; TCGA CESC -0.141; TCGA COAD -0.155; TCGA HNSC -0.205; TCGA KIRC -0.337; TCGA KIRP -0.583; TCGA LIHC -0.467; TCGA LUSC -0.095; TCGA OV -0.155; TCGA SARC -0.208; TCGA THCA -0.337; TCGA UCEC -0.17 |
hsa-miR-181d-5p | TAB3 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; OV; PRAD; THCA | MirTarget | TCGA BRCA -0.077; TCGA CESC -0.082; TCGA HNSC -0.134; TCGA KIRC -0.185; TCGA KIRP -0.121; TCGA LIHC -0.116; TCGA OV -0.053; TCGA PRAD -0.1; TCGA THCA -0.103 |
hsa-miR-181d-5p | HK2 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA BRCA -0.135; TCGA CESC -0.244; TCGA COAD -0.148; TCGA ESCA -0.209; TCGA HNSC -0.268; TCGA LUAD -0.258; TCGA LUSC -0.12; TCGA PRAD -0.185; TCGA STAD -0.21 |
hsa-miR-181d-5p | CSNK1G1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; THCA | MirTarget | TCGA BRCA -0.074; TCGA CESC -0.082; TCGA COAD -0.092; TCGA ESCA -0.145; TCGA HNSC -0.083; TCGA KIRC -0.051; TCGA LUAD -0.069; TCGA PRAD -0.079; TCGA THCA -0.104 |
hsa-miR-181d-5p | DHRS4 | 12 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; OV; SARC; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.083; TCGA COAD -0.164; TCGA ESCA -0.22; TCGA HNSC -0.131; TCGA KIRC -0.27; TCGA KIRP -0.307; TCGA LIHC -0.331; TCGA LUSC -0.1; TCGA OV -0.222; TCGA SARC -0.068; TCGA THCA -0.102; TCGA STAD -0.341 |
hsa-miR-181d-5p | ARF6 | 9 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD | MirTarget | TCGA CESC -0.143; TCGA COAD -0.133; TCGA ESCA -0.161; TCGA HNSC -0.222; TCGA LUAD -0.068; TCGA LUSC -0.128; TCGA PRAD -0.071; TCGA SARC -0.087; TCGA STAD -0.131 |
hsa-miR-181d-5p | NUS1 | 9 cancers: HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA | MirTarget | TCGA HNSC -0.104; TCGA KIRC -0.089; TCGA KIRP -0.102; TCGA LIHC -0.082; TCGA LUAD -0.097; TCGA LUSC -0.071; TCGA OV -0.063; TCGA PAAD -0.095; TCGA THCA -0.106 |
Enriched cancer pathways of putative targets